Drug Side Effects
Search
INTRAPULMONARY LYMPHADENOPATHY
INTRAPULMONARY LYMPHADENOPATHY
was reported 20 times
INTRAPULMONARY LYMPHADENOPATHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Provitamin D2 Compound [EPC]
2
0.0001
1
Vitamin D3 Analog [EPC]
1
0.0000
2
Nicotinic Acid [EPC]
3
0.0000
3
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
1
0.0000
4
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
1
0.0000
5
Programmed Death Receptor-1 Blocking Antibody [EPC]
4
0.0000
6
Androgen Receptor Inhibitor [EPC]
2
0.0000
7
Interleukin-17A Antagonist [EPC]
1
0.0000
8
Serotonin-3 Receptor Antagonist [EPC]
3
0.0000
9
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
10
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
11
Antidote [EPC]
1
0.0000
12
Purine Antimetabolite [EPC]
1
0.0000
13
Vitamin C [EPC]
4
0.0000
14
Interleukin-23 Antagonist [EPC]
1
0.0000
15
Sulfonylurea [EPC]
1
0.0000
16
Osmotic Laxative [EPC]
2
0.0000
17
GLP-1 Receptor Agonist [EPC]
3
0.0000
18
Calcium [EPC]
1
0.0000
19
Dihydropyridine Calcium Channel Blocker [EPC]
2
0.0000
20
Microtubule Inhibitor [EPC]
1
0.0000
21
Kinase Inhibitor [EPC]
3
0.0000
22
Proton Pump Inhibitor [EPC]
3
0.0000
23
Expectorant [EPC]
1
0.0000
24
Alkylating Drug [EPC]
1
0.0000
25
Corticosteroid [EPC]
5
0.0000
26
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
27
Vitamin B12 [EPC]
1
0.0000
28
Nonsteroidal Anti-inflammatory Drug [EPC]
4
0.0000
29
Thalidomide Analog [EPC]
1
0.0000
30
Platelet Aggregation Inhibitor [EPC]
1
0.0000